ArticleJHEP reports : innovation in hepatology2025

CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I.

Tong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.